Testing for the presence of HLA-DR4 antigen in a patient is used to determine the potential risk of developing of lyme arthritis from infection with Borrelia burgdorferi or vaccination with lyme vaccine.
10.0 mL Whole Blood in a Yellow Top Tube - ACD
72 hours Ambient
Collect only Monday through Thursday
Must be to testing facility with in 24 hours of collection
1.0 mL Whole Blood
A positive result indicates the presence of HLA-DR4 antigen which is associated with an increased risk of an adverse reaction to vaccination with Lyme disease vaccine
Testing for the presence of HLA-DR4 antigen in a patient is used to determine the potential risk of developing of lyme arthritis from infection with Borrelia burgdorferi or vaccination with lyme vaccine.
3 to 4 days
86816
00913333